Replies to post #42246 on Enzolytics Inc (ENZC)

[136]

So looking into Robert Moss, our new board member..

He's CMO of NASDAQ company Adamis Pharmaceutical Co. ADMP

They are currently working on an angle for inflammation related to covid. The product they have is called Tempol.

Adamis claims Tempol is

a Novel Investigational Anti-inflammatory and Antioxidant Drug for the Treatment of Respiratory Diseases Including COVID-19

wondering if we see any more ADMP / ENZC developments

hmm

I like it

$ENZC

ENZC

[God_Father]

Doubling down on these predictions from a week ago. If you've paid attention, you'll see why I've been saying "November to Remember". The fun starts now.

Best of luck

God_Father Friday, 11/06/20 12:26:35 PM
Re: God_Father post# 41433 0
Post #
41436
of 42244
PREDICTION;

1) Full 2019 filings will be published between 11/6 and 11/13

2) A Press Release regarding operations; GMP manufacturer, NSF/NIH funding, and/OR New board of directors member between 11/9 and 11/13

3) Full 2020 filings and going current will be published between 11/9 and 11/20

4) Attorney letter between 11/13 and 11/20

5) Press Release announcing merger finalization and operational activities 11/13 - 11/24

6) PPS by November 30th = 0.03 - 0.10